Sleep Apnea Implants Market Research Development, Top Companies, Trends and Growth 2019-2029 | Pillar Palatal LLC, LinguaFlex LLC, Nyxoah SA, ImThera, and Inspire Medical Systems
Increased stress in everyday life, improper lifestyle and extended working hours are some of the factors that cause sleep apnea due to improper and insufficient sleep cycles. The Obstructive sleep apnea is one of the most common and serious condition. In this condition, the muscles in the airway relax during sleep causing the airway to narrow, thereby blocking or hindering the natural flow of air into the lungs. One of the most common symptoms of sleep apnea is loud snoring. In order to reduce the snoring and improve the flow of air, Medtronic developed the Pillar Procedure which involves the use of pillar-like implants on the soft palate.
These implants support the palate as well as the tongue maintaining a gap for better flow of air. Pillar Palatal LLC then later was formed for the acquisition of the pillar procedure business from Medtronic. Another similar device is the LinguaFlex Tongue Retractor. This is a small device that flexible and is used to support the tongue base in order to prevent the backward collapse of the tongue. These type of sleep apnea implants can be easily implanted within 15 minutes through minimally invasive procedures.
Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8698
Nurostimulating devices for sleep apnea is another are that is being explored recently. These sleep apnea devices contain a small implantable stimulator that is connected to the base of the tongue. The implant may require an activation chip that allows remote operation of the stimulator or may be preprogrammed. This type of sleep apnea implants is designed to stimulate key tongue muscles to control the upper airway flow so as to reduce or eliminate sleep apnea in patients. Some of the companies that offer sleep apnea implants based on neurostimulation include, ImThera, Nyxoah SA and Inspire Medical Systems.
Sleep Apnea Implants Market: Drivers and Restraints
Rise in sleep disorders particularly obstructive sleep apnea is one of the main factors that dives the growth of the sleep apnea implants market. Increase in awareness leads to an increase in the number of patients diagnosed with sleep disorders that in turn increased the treatment rate. Thus an increase in awareness is also an important factor that drives the growth of the sleep apnea implants market. However, increased cost of the procedure, availability of a number of alternatives such as ventilators, masks and mouth cards hinder the growth of the sleep apnea implants market.
Sleep Apnea Implants Market: Segmentation
The global Sleep Apnea Implants market is segmented by drug class, route of administration, distribution channel and region:
Based on the product type, the global Sleep Apnea Implants market is segmented into:
- Neuromodulator Implants
- Tongue obstruction Implants
Based on the end users, the global Sleep Apnea Implants market is segmented into:
- Ambulatory Surgical Centers
- Specialty Clinics
Sleep Apnea Implants Market: Overview
Sleep Apnea Implants market consist of two major types of implants, which include neuromodulator implants and tongue obstruction implants. Tongue obstruction implants include implants such as the pillar procedure implants and other similar devices that support the tongue so as to prevent complete relaxation of the tongue that may obstruct the flow of air into the lungs. While the neuromodulator type of sleep apnea implants are relatively new in the sleep apnea implants market and are used to gently stimulate the tongue muscles to prevent complete relation of the muscle during sleep.
Sleep Apnea Implants Market: Regional Outlook
Rise in awareness, increased healthcare spending and technology advancements are some of the factors that drive the growth of the sleep apnea implants market in North America to take maximum share of the sleep apnea implants market.
Sleep Apnea Implants Market: Key Players
Pillar Palatal LLC, LinguaFlex LLC, Nyxoah SA, ImThera, and Inspire Medical Systems are some of the manufacturers that offer sleep apnea implants. Many players in the sleep apnea implants market focus on mergers and acquisitions as their major strategy for the growth of the product line in the sleep apnea implants market. For an instance, LivaNova PLC announced an agreement to acquire ImThera in December 2017.
Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-8698
The regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia-Pacific Excluding China and Japan (India, ASEAN, Australia & New Zealand)
- The Middle East and Africa (GCC, S. Africa, N. Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Explore Wide-ranging Coverage of FMI’s Healthcare Landscape
Centrifugal Blood Pump Market – A slew of cardiovascular products were launched for the management of cardiac disorders over the last decade and development of more are currently underway. With leading manufacturers expecting the demand to surge amid COVID-19, centrifugal blood pump sales are set to grow steadily through 2030.
Pharmaceutical Intermediates Market – The global diabetes prevalence in 2019 is estimated to be 9.3% (463 million people), rising to 10.2% (578 million) by 2030, and the number is rising rapidly. Pharmaceutical drugs have remained key to management of chronic diseases and other diseases.
Respiratory Inhaler Devices Market – A slew of new drugs were launched for the management of asthma and COPD over the last decade and development of more are currently underway. With leading drug manufacturers expecting the demand to surge amid COVID-19, respiratory inhaler sales are set to grow steadily through 2030.
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: email@example.com
For Media Enquiries: firstname.lastname@example.org